In last trading session, ReShape Lifesciences Inc (NASDAQ:RSLS) saw 2.02 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $0.38 trading at -$0.01 or -2.56% at ring of the bell on the day assigns it a market valuation of $4.29M. That closing price of RSLS’s stock is at a discount of -7531.58% from its 52-week high price of $29.00 and is indicating a premium of 21.05% from its 52-week low price of $0.30. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 37.87 million shares which gives us an average trading volume of 15.59 million if we extend that period to 3-months.
For ReShape Lifesciences Inc (RSLS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
Upright in the red during last session for losing -2.56%, in the last five days RSLS remained trading in the green while hitting it’s week-highest on Monday, 04/21/25 when the stock touched $0.38 price level, adding 22.84% to its value on the day. ReShape Lifesciences Inc’s shares saw a change of -91.48% in year-to-date performance and have moved 4.65% in past 5-day. ReShape Lifesciences Inc (NASDAQ:RSLS) showed a performance of -27.33% in past 30-days. Number of shares sold short was 0.69 million shares which calculate 1.14 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 80.05% during past 5 years.
ReShape Lifesciences Inc (NASDAQ:RSLS)’s Major holders
Insiders are in possession of 4.11% of company’s total shares while institution are holding 4.88 percent of that, with stock having share float percentage of 5.09%. Investors also watch the number of corporate investors in a company very closely, which is 4.88% institutions for ReShape Lifesciences Inc that are currently holding shares of the company.
On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 2.39 shares of worth $908.0 or 0.02% of the total outstanding shares. The later fund manager was in possession of 860.0 shares on Dec 31, 2024 , making its stake of worth around $326.0 in the company or a holder of 0.01% of company’s stock.
